These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16902941)

  • 1. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
    Peng JY; Vaidehi N; Hall SE; Goddard WA
    ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of human m1 muscarinic acetylcholine receptors with double mutations at the junction of TM VI and the third extracellular domain.
    Huang XP; Williams FE; Peseckis SM; Messer WS
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1129-39. PubMed ID: 9732369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta1-adrenergic receptor.
    Rezmann-Vitti LA; Nero TL; Jackman GP; Machida CA; Duke BJ; Louis WJ; Louis SN
    J Med Chem; 2006 Jun; 49(12):3467-77. PubMed ID: 16759089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonist binding in the rat muscarinic receptor A study by docking and X-ray crystallography.
    Tanczos AC; Palmer RA; Potter BS; Saldanha JW; Howlin BJ
    Comput Biol Chem; 2004 Dec; 28(5-6):375-85. PubMed ID: 15556478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
    Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
    Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of agonist potency and receptor coupling by mutations of Ser388Tyr and Thr389Pro at the junction of transmembrane domain VI and the third extracellular loop of human M(1) muscarinic acetylcholine receptors.
    Huang XP; Williams FE; Peseckis SM; Messer WS
    Mol Pharmacol; 1999 Oct; 56(4):775-83. PubMed ID: 10496961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
    Lee SY; Zhu SZ; el-Fakahany EE
    Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and dynamics of the full-length M1 muscarinic acetylcholine receptor studied by molecular dynamics simulations.
    Espinoza-Fonseca LM; Pedretti A; Vistoli G
    Arch Biochem Biophys; 2008 Jan; 469(1):142-50. PubMed ID: 17935687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT3 antagonists derived from aminopyridazine-type muscarinic M1 agonists.
    Rival Y; Hoffmann R; Didier B; Rybaltchenko V; Bourguignon JJ; Wermuth CG
    J Med Chem; 1998 Jan; 41(3):311-7. PubMed ID: 9464362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants for ATP-binding in proteins: a data mining and quantum chemical analysis.
    Mao L; Wang Y; Liu Y; Hu X
    J Mol Biol; 2004 Feb; 336(3):787-807. PubMed ID: 15095988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    FEBS Lett; 2005 Dec; 579(30):6726-32. PubMed ID: 16310776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7.
    Mazna P; Berka K; Jelinkova I; Balik A; Svoboda P; Obsilova V; Obsil T; Teisinger J
    Biochem Biophys Res Commun; 2005 Jul; 332(3):726-34. PubMed ID: 15913560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
    Matsui H; Lazareno S; Birdsall NJ
    Mol Pharmacol; 1995 Jan; 47(1):88-98. PubMed ID: 7838137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43)).
    Rezmann-Vitti LA; Louis SN; Nero TL; Jackman GP; Iakovidis D; Machida CA; Louis WJ
    Biochem Pharmacol; 2004 Aug; 68(4):675-88. PubMed ID: 15276075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.
    Abdul-Ridha A; López L; Keov P; Thal DM; Mistry SN; Sexton PM; Lane JR; Canals M; Christopoulos A
    J Biol Chem; 2014 Feb; 289(9):6067-79. PubMed ID: 24443568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular model of agonist and nonpeptide antagonist binding to the human V(1) vascular vasopressin receptor.
    Thibonnier M; Coles P; Conarty DM; Plesnicher CL; Shoham M
    J Pharmacol Exp Ther; 2000 Jul; 294(1):195-203. PubMed ID: 10871312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor.
    Fleck BA; Chen C; Yang W; Huntley R; Markison S; Nickolls SA; Foster AC; Hoare SR
    Biochemistry; 2005 Nov; 44(44):14494-508. PubMed ID: 16262250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.